TennCare patient wins experimental treatment as rare disease worsens
After about two years of battling TennCare to pay for an experimental treatment, a judge has ordered that a patient with a rare and painful disease receive care. TennCare, Tennessee’s insurance plan for the poor and disabled, has decided not to appeal. The could potentially impact thousands of others with rare diseases across the country, experts say.
- Senators Hear How Two-Midnight Rule Harms Patients, Hospitals
- 3 Management Lessons from a Supermarket Debacle
- Medicare Advantage Carriers See 'No Choice' But to Accept Cuts
- Physicians to Appeal 'Docs v. Glocks' Ruling in FL
- IOM Identifies GME Problems, Calls for Finance Changes
- Healthcare Costs Start With What We Eat
- Handshaking Spreads Germs. Get Over It.
- Revenue Cycles Get a Boost from Simple JPEG Files
- Hospitals Likely to Outsource ICD-10 at Launch
- Anatomy of 3 Health System Rebranding Efforts